Skip to main content

Joan Gavaldà Santapau

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Joan Gavaldà Santapau

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Tratamiento nebulizado con combinaciones antibióticas en modelos murinos de infección respiratoria por P. aeruginosa multiresistente. Proyecto neb-PaR

IP: Joan Gavaldà Santapau
Collaborators: Antonio Moreno Galdó, Albert Pahissa Berga, Javier Gomis Rodriguez, Marcos Pérez Carrasco
Funding agency: Instituto de Salud Carlos III
Funding: 77811.47
Reference: PI12/02903
Duration: 01/01/2013 - 31/12/2015

Estudio de la relevancia clínica de la resistencia a zoles en un modelo animal de aspergilosis invasora: caracterización de parámetros PD/PK

IP: Isabel Ruiz Camps
Collaborators: Nuria Fernández Hidalgo, Joan Gavaldà Santapau
Funding agency: Instituto de Salud Carlos III
Funding: 62920
Reference: PI09/00433
Duration: 01/01/2010 - 31/03/2013

Malalties Infeccioses

IP: Albert Pahissa Berga
Collaborators: M Teresa Martin Gomez, Adria Curran Fàbregas, Oscar Len Abad, Vicenç Falcó Ferrer, Manuel Crespo Casal, Inmaculada Ocaña Rivera, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Esteve Ribera Pascuet, Ma Dolores Rodríguez Pardo, Israel Molina Romero, Carles Pigrau Serrallach, Isabel Ruiz Camps
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2009 SGR 86
Duration: 01/01/2010 - 30/04/2014

Estudio in vitro e in vivo de la eficacia de antimicrobianos para la erradicación de biopelículas de S. aureus (SA) y Candida spp. (CAN) formadas sobre materiales sintéticos, particularmente catéteres venosos centrales

IP: Joan Gavaldà Santapau
Collaborators: M Teresa Martin Gomez, Albert Pahissa Berga, Javier Gomis Rodriguez, Nuria Fernández Hidalgo, Ma Dolores Rodríguez Pardo
Funding agency: Instituto de Salud Carlos III
Funding: 100717.98
Reference: PI070394
Duration: 01/01/2008 - 30/12/2010

Related news

The preliminary results of the first cross-sectional study with adolescents and young people aged 11 to 25 in the municipalities of Lobito and Cubal, Angola, show that more than half of the female participants have reported experiencing sexual violence.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Paula Isabel Roldan Caballero

Paula Isabel Roldan Caballero

Tècnic/a Superior Recerca
Academic Research Organisation (ARO)
Clinical Core Facilities
External Strategy Directorate
Read more
Martina Garriga Ferrer

Martina Garriga Ferrer

P Management and Admin. Project manager
External Strategy Directorate
Read more
Emily Betancourt Fernández

Emily Betancourt Fernández

Predoctoral researcher
Molecular Medical Imaging
Read more
Arturo Miguel Battaglia Cáceres

Arturo Miguel Battaglia Cáceres

Predoctoral researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.